rs216310

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000552.5(VWF):​c.4641T>C​(p.Thr1547Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.647 in 1,601,608 control chromosomes in the GnomAD database, including 341,539 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.72 ( 39994 hom., cov: 30)
Exomes 𝑓: 0.64 ( 301545 hom. )

Consequence

VWF
NM_000552.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:13

Conservation

PhyloP100: -1.16
Variant links:
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 12-6018777-A-G is Benign according to our data. Variant chr12-6018777-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 256680.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-6018777-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.16 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.885 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VWFNM_000552.5 linkc.4641T>C p.Thr1547Thr synonymous_variant Exon 28 of 52 ENST00000261405.10 NP_000543.3 P04275-1
VWFXM_047429501.1 linkc.4641T>C p.Thr1547Thr synonymous_variant Exon 28 of 52 XP_047285457.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VWFENST00000261405.10 linkc.4641T>C p.Thr1547Thr synonymous_variant Exon 28 of 52 1 NM_000552.5 ENSP00000261405.5 P04275-1
VWFENST00000538635.5 linkn.421-24843T>C intron_variant Intron 5 of 5 4

Frequencies

GnomAD3 genomes
AF:
0.716
AC:
108540
AN:
151694
Hom.:
39958
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.893
Gnomad AMI
AF:
0.688
Gnomad AMR
AF:
0.753
Gnomad ASJ
AF:
0.689
Gnomad EAS
AF:
0.748
Gnomad SAS
AF:
0.773
Gnomad FIN
AF:
0.546
Gnomad MID
AF:
0.772
Gnomad NFE
AF:
0.620
Gnomad OTH
AF:
0.723
GnomAD3 exomes
AF:
0.689
AC:
169960
AN:
246712
Hom.:
60268
AF XY:
0.685
AC XY:
91410
AN XY:
133488
show subpopulations
Gnomad AFR exome
AF:
0.902
Gnomad AMR exome
AF:
0.807
Gnomad ASJ exome
AF:
0.687
Gnomad EAS exome
AF:
0.764
Gnomad SAS exome
AF:
0.757
Gnomad FIN exome
AF:
0.548
Gnomad NFE exome
AF:
0.619
Gnomad OTH exome
AF:
0.678
GnomAD4 exome
AF:
0.639
AC:
926963
AN:
1449796
Hom.:
301545
Cov.:
62
AF XY:
0.642
AC XY:
462459
AN XY:
720526
show subpopulations
Gnomad4 AFR exome
AF:
0.905
Gnomad4 AMR exome
AF:
0.802
Gnomad4 ASJ exome
AF:
0.689
Gnomad4 EAS exome
AF:
0.738
Gnomad4 SAS exome
AF:
0.751
Gnomad4 FIN exome
AF:
0.547
Gnomad4 NFE exome
AF:
0.614
Gnomad4 OTH exome
AF:
0.667
GnomAD4 genome
AF:
0.716
AC:
108630
AN:
151812
Hom.:
39994
Cov.:
30
AF XY:
0.718
AC XY:
53229
AN XY:
74160
show subpopulations
Gnomad4 AFR
AF:
0.892
Gnomad4 AMR
AF:
0.753
Gnomad4 ASJ
AF:
0.689
Gnomad4 EAS
AF:
0.748
Gnomad4 SAS
AF:
0.773
Gnomad4 FIN
AF:
0.546
Gnomad4 NFE
AF:
0.620
Gnomad4 OTH
AF:
0.719
Alfa
AF:
0.647
Hom.:
9534
Bravo
AF:
0.739

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:5
Apr 10, 2018
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

Allele frequency is common in at least one population database (frequency: 90.157% in gnomAD_Exomes) based on the frequency threshold of 0.5% for this gene. Variant was observed in a homozygous state in population databases more than expected for disease. A synonymous variant not located in a splice region. -

Apr 13, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 17, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 03, 2020
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.Thr1547Thr variant in VWF is classified as benign because it does not alter an amino acid residue, is not located within the splice consensus site, and computational splice prediction tools do not predict an impact on splicing. It has been identified in 90% (22058/24566) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1, BP4, BP7. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

von Willebrand disease type 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

von Willebrand disease type 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

von Willebrand disease type 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary von Willebrand disease Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.071
DANN
Benign
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs216310; hg19: chr12-6127943; COSMIC: COSV54625202; COSMIC: COSV54625202; API